Clinical Trial Update: Trial of Proton Pump Inhibitor With Prokinetics or Placebo in Patients With Laryngopharyngeal Reflux Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a proton pump inhibitor with a prokinetic agent versus placebo in patients with laryngopharyngeal reflux disease; the current status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Laryngopharyngeal Reflux Disease

Drugs mentioned

• Prokinetic Agent (prokinetic agent)
• Proton Pump Inhibitor (proton pump inhibitor)

Snippet

Sponsor: Samsung Medical Center | Conditions: Laryngopharyngeal Reflux Disease | Phase 3 | Status: UNKNOWN